Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00594945|
Recruitment Status : Completed
First Posted : January 16, 2008
Results First Posted : July 1, 2014
Last Update Posted : July 1, 2014
|Study Design||Allocation: Non-Randomized; Intervention Model: Crossover Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Based on preliminary PK data, the study was terminated early prior to achieving planned enrollment numbers.
Cohort 1 was dosed at 2mg. Cohort 2 was dosed at 3mg. Two subjects participated in both Cohorts.